Treatment of Adult Dermatomyositis in Chronic IIM-Associated Interstitial Lung Disease

This protocol addresses adult dermatomyositis presenting in the context of chronic interstitial lung disease associated with idiopathic inflammatory myopathy (IIM). The co-occurrence of IIM-associated ILD represents a specific sub-population requiring a tailored treatment strategy.

Management of this condition involves immunosuppressive therapy, with corticosteroids forming the backbone of treatment. Whether additional agents are required alongside steroids depends on individual patient factors.